Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |